Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combining repurposed drugs to treat colorectal cancer
Diana Duarte, Nuno Vale
Drug Discovery Today (2021) Vol. 27, Iss. 1, pp. 165-184
Closed Access | Times Cited: 18

Showing 18 citing articles:

Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4‐mediated Ferroptosis in Colorectal Cancer
Kaixuan Zeng, Weihao Li, Yue Wang, et al.
Advanced Science (2023) Vol. 10, Iss. 25
Open Access | Times Cited: 64
Colorectal cancer: Recent advances in management and treatment
Hiba Fadlallah, Jad El Masri, Hiam Fakhereddine, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 9, pp. 1136-1156
Open Access | Times Cited: 17
Inhaled Indomethacin-Loaded Liposomes as Potential Therapeutics against Non-Small Cell Lung Cancer (NSCLC)
Sruthi Sarvepalli, Vineela Parvathaneni, Gautam Chauhan, et al.
Pharmaceutical Research (2022) Vol. 39, Iss. 11, pp. 2801-2815
Closed Access | Times Cited: 25
A cascade nanoplatform for intelligent response to tumor microenvironment and collaborative cancer therapy
Tong Li, Mingjie Rong, Yuzhu Wang, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 10, pp. 2537-2546
Closed Access | Times Cited: 5
Ramipril, perindopril and trandolapril as potential chemosensitizers in ovarian cancer: considerations for drug repurposing
Katarzyna Regulska, Paulina Gieremek, Marcin Michalak, et al.
Drug Discovery Today (2025), pp. 104331-104331
Closed Access
Multi-Omics-Based Analysis of the Effect of Longevity Genes on the Immune Relevance of Colorectal Cancer
Yichu Huang, Guangtao Min, Hongpeng Wang, et al.
Biomedicines (2025) Vol. 13, Iss. 5, pp. 1085-1085
Open Access
Focusing on New Piperazinyl‐methyl‐3(2H)pyridazinone Based Derivatives: Design, Synthesis, Anticancer Activity and Computational Studies
İrem Bozbey, Gülce Taşkor Önel, Senem Akkoç, et al.
ChemistrySelect (2023) Vol. 8, Iss. 25
Closed Access | Times Cited: 8
Pitavastatin and Ivermectin Enhance the Efficacy of Paclitaxel in Chemoresistant High-Grade Serous Carcinoma
Mariana Nunes, Diana Duarte, Nuno Vale, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4357-4357
Open Access | Times Cited: 11
Sparassis latifolia and exercise training as complementary medicine mitigated the 5-fluorouracil potent side effects in mice with colorectal cancer: bioinformatics approaches, novel monitoring pathological metrics, screening signatures, and innovative management tactic
Navid Abedpoor, Farzaneh Taghian, Khosro Jalali Dehkordi, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
A novel TNKS/USP25 inhibitor blocks the Wnt pathway to overcome multi-drug resistance in TNKS-overexpressing colorectal cancer
Hongrui Zhu, Yamin Gao, Liyun Liu, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 1, pp. 207-222
Open Access | Times Cited: 6
The Antineoplastic Effect of Carboplatin Is Potentiated by Combination with Pitavastatin or Metformin in a Chemoresistant High-Grade Serous Carcinoma Cell Line
Mariana Nunes, Diana Duarte, Nuno Vale, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 97-97
Open Access | Times Cited: 8
Raddeanin A Inhibits Colorectal Cancer Growth and Ameliorates Oxaliplatin Resistance Through the WNT/β-Catenin Signaling Pathway
Guoqin Chen, Yanhong Zhang, Xijie Chen, et al.
Cancer Biotherapy and Radiopharmaceuticals (2024)
Closed Access | Times Cited: 1
Repurposing Drugs for Overcoming Therapy Resistance in Colon Cancer – A Review
Mahdi Darvishi, Amir Chekeni, Mohammad Fazelhosseini, et al.
Journal of Angiotherapy (2024) Vol. 8, Iss. 2
Open Access
A combined treatment with Ursolic acid and Solasodine inhibits colorectal cancer progression through the AKT1/ERK1/2-GSK-3β-β-catenin axis
Yiren Yang, Pengyu Liu, Yue Jin, et al.
Phytomedicine (2024) Vol. 135, pp. 156068-156068
Closed Access
Novel Drug Combinations in Lung Cancer: New Potential Synergies Between 5-FU and Repurposed Drugs
Eduarda Ribeiro, Nuno Vale
Applied Sciences (2024) Vol. 14, Iss. 21, pp. 9658-9658
Open Access
Ivermectin Strengthens Paclitaxel Effectiveness in High-Grade Serous Carcinoma in 3D Cell Cultures
Mariana Nunes, Sara Ricardo
Pharmaceuticals (2024) Vol. 18, Iss. 1, pp. 14-14
Open Access
Old drugs and new opportunities—Drug repurposing in colon cancer prevention
Vemula Sarojamma, Manoj Kumar Gupta, Jeelan Basha Shaik, et al.
Elsevier eBooks (2023), pp. 223-235
Closed Access
Chemotherapy/anti-inflammatory drug co-delivery system based on ortho ester-modified pluronic L61 for reversing tumor multidrug resistance
Junnan Li, Junjie Hu, Ying Zhou, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 91, pp. 105210-105210
Closed Access
IVERMECTIN AS A POTENTIAL DRUG IN INHIBITING COLORECTAL CANCER CELL GROWTH
Patil Py, Ettaboina Sk, Thenmozhli Gs, et al.
International Journal of Biology Pharmacy and Allied Sciences (2022) Vol. 11, Iss. 10
Open Access
Page 1

Scroll to top